EMEA-001724-PIP01-14

Key facts

Active substance
Levomilnacipran
Therapeutic area
Neurology
Decision number
P/0128/2015
PIP number
EMEA-001724-PIP01-14
Pharmaceutical form(s)
  • Prolonged-release capsule
  • Capsule (hard)
Condition(s) / indication(s)
Treatment of stroke
Route(s) of administration
Oral use
Contact for public enquiries
Pierre Fabre Medicament
France
Tel. +33 149108081
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating